![](/img/cover-not-exists.png)
FRI0201 Analysis of infection risk in patients with limited return of peripheral B cells after a period of 2 years or more following any rituximab treatment course in RA clinical trials:
Mease, P., van Vollenhoven, R., Durez, P., Sheeran, T., Dougados, M., Gόmez-Reino, J.J., Tyson, N., Mehbob, A., Lehane, P.B.Volume:
71
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2012-eular.2658
Date:
June, 2013
File:
PDF, 70 KB
english, 2013